These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32281038)

  • 1. Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study.
    Moccia M; Frau J; Carotenuto A; Butera C; Coghe G; Barbero P; Frontoni M; Groppo E; Giovannelli M; Del Carro U; Inglese C; Frasson E; Castagna A; Buccafusca M; Latino P; Nascimbene C; Romano M; Liotti V; Lanfranchi S; Rapisarda L; Lori S; Esposito M; Maggi L; Petracca M; Lo Fermo S; Altavista MC; Bono F; Eleopra R; Brescia Morra V
    Neurol Sci; 2020 Oct; 41(10):2781-2792. PubMed ID: 32281038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis.
    Novarella F; Carotenuto A; Cipullo P; Iodice R; Cassano E; Spiezia AL; Capasso N; Petracca M; Falco F; Iacovazzo C; Servillo G; Lanzillo R; Brescia Morra V; Moccia M
    Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study.
    Datta Gupta A; Visvanathan R; Cameron I; Koblar SA; Howell S; Wilson D
    BMC Neurol; 2019 May; 19(1):96. PubMed ID: 31078139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goal-Setting in Multiple Sclerosis-Related Spasticity Treated with Botulinum Toxin: The GASEPTOX Study.
    Baccouche I; Bensmail D; Leblong E; Fraudet B; Aymard C; Quintaine V; Pottier S; Lansaman T; Malot C; Gallien P; Levy J
    Toxins (Basel); 2022 Aug; 14(9):. PubMed ID: 36136520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.
    Bhakta BB; Cozens JA; Chamberlain MA; Bamford JM
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):217-21. PubMed ID: 10896696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does botulinum toxin treatment improve upper limb active function?
    Levy J; Molteni F; Cannaviello G; Lansaman T; Roche N; Bensmail D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):234-240. PubMed ID: 29960017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force.
    Dressler D; Bhidayasiri R; Bohlega S; Chahidi A; Chung TM; Ebke M; Jacinto LJ; Kaji R; Koçer S; Kanovsky P; Micheli F; Orlova O; Paus S; Pirtosek Z; Relja M; Rosales RL; Sagástegui-Rodríguez JA; Schoenle PW; Shahidi GA; Timerbaeva S; Walter U; Saberi FA
    J Neurol; 2017 Jan; 264(1):112-120. PubMed ID: 27787630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local botulinum toxin type A injections in the treatment of spastic toes.
    Suputtitada A
    Am J Phys Med Rehabil; 2002 Oct; 81(10):770-5. PubMed ID: 12362118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians).
    Bensmail D; Hanschmann A; Wissel J
    J Med Econ; 2014 Sep; 17(9):618-25. PubMed ID: 24841450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum Toxins Type A (Bont-A) in the Management of Lower Limb Spasticity in Children: A Systematic Literature Review and Bayesian Network Meta-analysis.
    Guyot P; Kalyvas C; Mamane C; Danchenko N
    J Child Neurol; 2019 Jun; 34(7):371-381. PubMed ID: 30803305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial.
    Paoloni M; Giovannelli M; Mangone M; Leonardi L; Tavernese E; Di Pangrazio E; Bernetti A; Santilli V; Pozzilli C
    Clin Rehabil; 2013 Sep; 27(9):803-12. PubMed ID: 23543344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does botulinum toxin improve the function of the patient with spasticity after stroke?
    Cardoso E; Pedreira G; Prazeres A; Ribeiro N; Melo A
    Arq Neuropsiquiatr; 2007 Sep; 65(3A):592-5. PubMed ID: 17876396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis.
    Marvulli R; Megna M; Citraro A; Vacca E; Napolitano M; Gallo G; Fiore P; Ianieri G
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31266172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
    Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of spasticity in spinal cord injury with botulinum toxin.
    Palazón-García R; Alcobendas-Maestro M; Esclarin-de Ruz A; Benavente-Valdepeñas AM
    J Spinal Cord Med; 2019 May; 42(3):281-287. PubMed ID: 29869974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multimuscle treatment of spasticity in adults patients with botulinum toxin].
    Bensmail D; Roche N
    Ann Readapt Med Phys; 2007 Jan; 50 Suppl 1():S4-6. PubMed ID: 17550811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Botulinum Toxin Injections on Plantar Flexor Spasticity in Different Phases After Stroke: A Secondary Analysis From a Double-Blind, Randomized Trial.
    Oh HM; Park GY; Choi YM; Koo HJ; Jang Y; Im S
    PM R; 2018 Aug; 10(8):789-797. PubMed ID: 29510234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.